Education

POGO Multidisciplinary Symposium on Childhood Cancer

Date: November 4-5, 2022
Location: Sheraton Centre, Toronto (123 Queen St. W.)

 

Register Now

View Program

POGO is thrilled to host a long-awaited reunion of the pediatric oncology community at our signature education event of the year!

The 2022 POGO Multidisciplinary Symposium on Childhood Cancer – Central Nervous System Tumours – will examine clinical and scientific advances in the diagnosis and treatment of central nervous system (CNS) tumours in children and adolescents and highlight the impact of this disease on patients, families and survivors.

This year’s hybrid conference features options for in-person or virtual attendance and promises something for every healthcare provider invested in the care of children with cancer and their families.

Accreditation

Royal College Maintenance of Certification Section 1: 11.5 hours

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 11.5 hours (credits are automatically calculated).

Learning Objectives

Participants will be able to:

  1. Discuss cancer predisposition syndromes in the context of pediatric brain tumours and explain implications for treatment.
  2. Explain the goal of the pediatric rare cancer tumour registry and describe the challenges of addressing therapy & diagnostics in rare pediatric diseases, including CNS tumours.
  3. Describe the role of targeted agents in advancing the treatment of CNS tumours.
  4. Discuss the challenges of bringing a new pediatric cancer drug to market and consider system improvements to address those challenges.
  5. Explain the benefits of and eligibility criteria for proton therapy, MRI-guided ultrasound and laser interstitial thermal therapy (LITT) in the context of pediatric CNS tumours.
  6. Summarize long-term outcomes of pediatric CNS tumour survivors at the population level.
  7. Describe the clinical and biological behavior of childhood type brain cancers in adolescents and young adults.
  8. Review the psychosocial impacts of CNS tumour diagnosis, treatment and late effects on patients and describe various interventions.
  9. Identify practical strategies for effectively communicating with CNS patients and survivors about their sexual health.
  10. Describe the particular challenges of caring for patients with CNS tumours at the end of life and summarize strategies to improve palliative care.
  11. Review rehabilitation options for pediatric CNS tumour survivors.
  12. Debate case studies related to family decision-making in the context of pediatric CNS tumours and discuss strategies to assist families with making difficult decisions.

(* NOTE: Only the following learning objectives are relevant for participants who choose the virtual registration option: 1, 3, 4, 5.)

General Questions?
Contact education@pogo.ca.